Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 44 | 68 | 165 | 140 | 109 |
| Cost of Goods | 33 | 54 | 136 | 65 | 99 |
| Gross Profit | 11 | 14 | 29 | 75 | 10 |
| Operating Expenses | 3,293 | 3,903 | 4,253 | 3,360 | 2,679 |
| Operating Income | -3,249 | -3,835 | -4,088 | -3,220 | -2,570 |
| Other Income | 60 | 44 | -27 | -7 | -24 |
| Pre-tax Income | -3,189 | -3,791 | -4,115 | -3,227 | -2,594 |
| Income Tax | -4 | -7 | -15 | -13 | -17 |
| Net Income Continuous | -3,185 | -3,784 | -4,100 | -3,214 | -2,577 |
| Net Income | $-3,185 | $-3,784 | $-4,100 | $-3,214 | $-2,577 |
| EPS Basic Total Ops | -0.11 | -0.13 | -0.16 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.11 | -0.13 | -0.15 | -0.11 | -0.10 |
| EPS Diluted Total Ops | -0.11 | -0.13 | -0.16 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.11 | -0.13 | -0.15 | -0.11 | -0.10 |
| EBITDA(a) | $-3,233 | $-3,819 | $-4,074 | $-3,205 | $-2,555 |